Text Size
51 studies found for:    "Encephalitis, Japanese"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed
Has Results 		Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: JE-VAX
22 Completed
Has Results 		Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
23 Completed
Has Results 		Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
24 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
25 Completed Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
26 Completed
Has Results 		A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
Condition: Japanese Encephalitis
Interventions: Biological: ChimeriVax™-JE;   Biological: JE-VAX®
27 Active, not recruiting Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects
Conditions: Rabies;   Japanese Encephalitis
Interventions: Biological: Rabies;   Biological: Japanese Encephalitis
28 Active, not recruiting Open-label, Randomized Study in a Pediatric Population in a JEV(Japanese Encephalitis Vaccine)-Endemic Country
Condition: Japanese Encephalitis
Intervention: Biological: IXIARO
29 Completed Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers
Conditions: Rabies;   Japanese Encephalitis;   Pre-Exposure Prophylaxis
Interventions: Biological: Three 1 mL doses of Rabies vaccine and two JE vaccine;   Biological: Three 0.5 mL doses of Rabies vaccine and two JE vaccine;   Biological: Three 0.1mL doses of Rabies Vaccine and two JE vaccine;   Biological: Two 0.1mL doses of Rabies vaccine and two JE vaccine;   Biological: Two doses of JE vaccine
30 Withdrawn Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination
Condition: Japanese Encephalitis
Intervention: Biological: IXIARO
31 Completed
Has Results 		Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine
Condition: Japanese Encephalitis
Interventions: Biological: Live attenuated Japanese encephalitis virus;   Biological: ChimeriVax™ diluent (Placebo)
32 Completed
Has Results 		Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: ChimeriVax-JE, Japanese Encephalitis vaccine;   Biological: 0.9% Saline
33 Completed
Has Results 		A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX
Condition: Japanese Encephalitis
Interventions: Biological: ChimeriVax™-JE vaccine;   Biological: JE-VAX® vaccine
34 Completed
Has Results 		Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)
Conditions: Japanese Encephalitis;   Yellow Fever
Interventions: Biological: Live attenuated Japanese encephalitis virus; Yellow fever virus;   Biological: Yellow fever virus; Live attenuated Japanese encephalitis virus
35 Completed
Has Results 		Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age
Condition: Japanese Encephalitis
Interventions: Biological: ChimeriVax™-JE;   Biological: Japanese Encephalitis Inactivated Mouse Brain Vaccine
36 Completed This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population
Condition: Japanese Encephalitis
Intervention: Biological: IXIARO®
37 Completed Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: HAVRIX
38 Completed Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling
Condition: Japanese Encephalitis
Intervention: Biological: IC51
39 Active, not recruiting Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study
Condition: Japanese Encephalitis
Interventions: Procedure: Blood draw;   Biological: IC51 has given in the parent study IC51-322
40 Recruiting Lot-to-lot Consistency Trial of JE Live Attenuated SA 14-14-2 Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: JE live attenuated SA 14-14-2 vaccine
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results
† Indicates status has not been verified in more than two years